Panagora Asset Management Inc Cidara Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$2.06 - $3.01 $978 - $1,429	-475 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$1.99 - $3.25 $35,238 - $57,551	-17,708 Reduced 97.39%	475 $1,000
Q3 2020 Nov 13, 2020	BUY	$2.85 - $4.1 $1,353 - $1,947	475 Added 2.68%	18,183 $52,000
Q2 2020 Aug 12, 2020	BUY	$2.39 - $4.0 $42,322 - $70,832	17,708 New	17,708 $65,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.23B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.